Use of implantable venous access devices in children with severe hemophilia: Benefits and burden

Haematologica

Volumn 89, Issue 2, 2004, Pages 189-194

  Van Dijk, Karin ^a,b   Van Der Bom, Johanna G ^a,b   Bax, Klaas M A ^d   Van Der Zee, David C ^c   Van Den Berg, H M H Marijke ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d NONE

Author keywords

Hemophilia; Port a Cath; Prophylaxis

Indexed keywords

ANTIBIOTIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; ALLOANTIBODY; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9;

ARTICLE; BLEEDING; CATHETER INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; HEMOPHILIA A; HEMOPHILIA B; HUMAN; IMPLANT; INFECTION RATE; INTRAVENOUS CATHETER; PRESCHOOL CHILD; PROPHYLAXIS; RISK BENEFIT ANALYSIS; THROMBOSIS; VASCULAR ACCESS; AGE; BIOSYNTHESIS; COHORT ANALYSIS; COMPARATIVE STUDY; DEVICE REMOVAL; EVALUATION; FEMALE; HOME CARE; IMMUNOLOGY; INDWELLING CATHETER; INFANT; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PROSPECTIVE STUDY;

AGE FACTORS; CATHETERS, INDWELLING; CHILD, PRESCHOOL; COHORT STUDIES; DEVICE REMOVAL; FACTOR IX; FACTOR VIII; FEMALE; HEMOPHILIA A; HEMOPHILIA B; HEMORRHAGE; HOME NURSING; HUMANS; INFANT; INFECTION; INFUSIONS, INTRAVENOUS; ISOANTIBODIES; MALE; PROSPECTIVE STUDIES; THROMBOSIS;

EID: 2942612981     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Löfqvist T, Nilsson IM, Berntorp E, Pettersson H. Haemophilia prophylaxis in young patients: a long-term follow-up. J Intern Med 1997;241:395-400.
2. Van den Berg HM, Fischer K, Mauser-Bunschoten EP, Beek FJA, Roosendaal G, Van der Bom JG, et al. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. Br J Haematol 2001;112:561-5.
3. Fischer K, Van der Bom JG, Prejs R, Mauser-Bunschoten EP, Roosendaal G, De Kleijn P, et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood 2002;99:2337-41.
4. Liesner RJ, Vora AJ, Hann IM, Lilleyman JS. Use of central venous catheters in children with severe congenital coagulopathy. Br J Haematol 1995;91:203-7.
5. Perkins JL, Johnson VA, Osip JM, Christie BA, Nelson SC, Moertel CL, et al. The use of implantable venous access devices (IVADs) in children with hemophilia. J Pediatr Hematol Oncol 1997;19:339-44.
6. Collins PW, Khair KS, Liesner R, Hann IM. Complications experienced with central venous catheters in children with congenital bleeding disorders. Br J Haematol 1997;99:206-8.
7. Ljung R, Van den Berg HM, Petrini P. Port-a-cath usage in children with haemophilia: experience in 53 cases. Acta Paediatr 1998;87:1051-4.
8. Santagostino E, Gringer A, Muca-Perja M, Mannucci PM. A prospective clinical trial of implantable central venous access in children with haemophilia. Br J Haematol 1998;102:1224-8.
9. McMahon C, Smith J, Khair K, Liesner R, Hann IM, Smith OP. Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome. Br J Haematol 2000;110:461-8.
10. th Annual Meeting 1996; San Diego, CA: USA.[abstract]
11. Miller K, Buchanan G, Zappa S. Implantable venous access devices in children with hemophilia: a report of low infection rates. J Pediatr 1998;132:934-8.
12. Vidler V, Richards M, Vora A. Central venous catheter-associated thrombosis in severe haemophilia. Br J Haematol 1999;104:461-4.
13. Blanchette VS, Al Trabolsi H, Stain AM, Sparling CR, Massicotte MP, Daneman A, et al. High risk of central venous line-associated thrombosis in boys with hemophilia. Blood 1999; 94:234a [abstract].
14. Journeycake JM, Quinn CT, Miller KL, Zajac JL, Buchanan GR. Catheter related deep venous thrombosis in children with hemophilia. Blood 2001;98:1727-31.
15. Ljung R, Petrini P, Lindgren AK, Berntorp E. Implantable central venous catheter facilitates prophylactic treatment in children with hemophilia. Acta Paediatr 1992;81:918-20.
16. Van den Berg HM, Fischer K, Roosendaal G, Mauser-Bunschoten EP. The use of the port-a-cath in children with haemophilia - a review. Haemophilia 1998;4:489-20.
17. Verbruggen B, Novakova I, Wessels H, Boezeman J, Van den Berg HM, Mauser-Bunschoten EP. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thromb Haemost 1995;73:247-51.
18. Kasper CK, Aledort LM, Aronson D, Counts RB, Edson JR, van Eys J, et al. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975; 43:612.
19. Bollard CM, Teague CR, Berry EW, Ockelford PA. The use of central venous catheters (portacaths) in children with haemophilia. Haemophilia 2000;6:66-70.
20. Medeiros D, Miller KL, Rollins NK, Buchanan GR. Contrast venography in young hemophiliacs with implantable central venous access devices. Haemophilia 1998;4:10-5.
21. Warrier I, Baird-Cox K, Lusher JM. Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experience. Haemophilia 1997; 3:194-8.
22. Morado M, Jimenez-Yuste V, Villar A. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia 2001;7:551-6.
23. Grassi CJ, Polak JF. Axillary and subclavian venous thrombosis: follow-up evaluation with color Doppler flow US and venography. Radiology 1990;175:651-4.